For many women, a diagnosis of gestational diabetes during pregnancy is a temporary health challenge, managed with diet and, sometimes, medication. But increasingly, doctors are recognizing that what appears to be gestational diabetes can, in some cases, be the first sign of a rarer, genetically-linked form of diabetes called Maturity-Onset Diabetes of the Young, or MODY. Specifically, MODY-2, linked to a variation in the glucokinase gene, is often revealed during pregnancy, presenting a unique set of considerations for both mother and child. Understanding this connection – and the often subtle clues it presents – is crucial for appropriate diagnosis and care.
MODY, as a whole, accounts for roughly 2 to 3% of all diabetes cases, making it less common than type 1 or type 2 diabetes. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) explains that these are monogenic forms of diabetes, meaning they are caused by a mutation in a single gene. MODY-2, the most prevalent type, affects approximately 1 in 1,000 people with diabetes. The challenge lies in its often-mild presentation, frequently going undiagnosed for years, or even decades, until a woman becomes pregnant.
The Subtle Signs of MODY-2
One of the key difficulties in identifying MODY-2 is the lack of obvious symptoms. As Dr. Anne Vambergue, a leading expert in the field, points out, “It’s often the case that there are no clinical symptoms, which is why this diabetes is likely underdiagnosed.” Typically, individuals with MODY-2 exhibit a modestly elevated fasting blood glucose level – generally between 1 g/L and 1.26 g/L – that remains stable over time. This subtle elevation often doesn’t trigger immediate concern, and may be dismissed as a minor irregularity. An elevated HbA1c, ranging from 5.6% to 6.5%, can also be an indicator, though still within a range that doesn’t immediately signal typical diabetes.
The diagnostic process can be further complicated by the physiological changes of pregnancy. Glycemia levels are often lower in early pregnancy, meaning a previously unnoticed mild elevation can become apparent during prenatal screening. In fact, MODY-2 accounts for a little over 1% of all gestational diabetes diagnoses. This is why a careful medical history, including family history of mild hyperglycemia, is so important when evaluating a patient with gestational diabetes who doesn’t fit the typical risk profile – someone who isn’t overweight and doesn’t have other common risk factors.
Family Screening and Genetic Testing
Once MODY-2 is suspected in an individual, genetic testing is the definitive diagnostic step. But what about family members? Targeted screening of relatives is recommended once a case is identified. The initial step involves a fasting blood glucose test. If the result exceeds 1 g/L, genetic testing is then offered, with informed consent. This testing is typically performed by a specialized endocrinologist or diabetologist.
Navigating Pregnancy with MODY-2
For women with known MODY-2 who are planning a pregnancy, preconception counseling is essential. This consultation focuses on several key areas: the 50% risk of passing the genetic variant to their child, the potential need for insulin therapy during pregnancy, and the importance of maintaining a well-controlled HbA1c level – ideally below 6.5% – to minimize the risk of congenital malformations.
The impact of MODY-2 on fetal growth is a complex consideration. If the fetus inherits the GCK variant, growth may be unaffected, as the altered gene doesn’t trigger excessive insulin production in response to maternal hyperglycemia. In such cases, insulin treatment for the mother may not be necessary. However, if the mother is treated with insulin despite the fetal genotype, there’s a risk of intrauterine growth restriction, necessitating close monitoring. Conversely, if the fetus *doesn’t* inherit the variant, their insulin secretion – and therefore their growth – could be stimulated by the mother’s elevated blood sugar, potentially leading to macrosomia (excessive birth weight) and requiring maternal treatment.
When the fetal genotype is unknown – which is often the case – clinicians must make informed decisions based on fetal growth as assessed by repeated ultrasounds. Some practitioners advocate for initiating insulin therapy if fetal growth exceeds the 75th percentile, while others prefer to treat as if it were a standard case of gestational diabetes, aiming for recommended pregnancy glucose targets. There is currently no universally accepted protocol, and decisions are made on a case-by-case basis, in shared decision-making with the expectant mother.
Diagnosis After Pregnancy and Long-Term Outlook
It’s not uncommon for a MODY-2 diagnosis to emerge *after* a woman’s first pregnancy. In these cases, the mother is managed as if she had typical gestational diabetes, and the diagnosis is often made retrospectively when the child’s hyperglycemia is detected shortly after birth, prompting genetic testing for both mother and child.
Outside of pregnancy, the long-term prognosis for individuals with MODY-2 is generally highly quality. Unlike other forms of diabetes, MODY-2 doesn’t typically carry an increased risk of micro- or macrovascular complications. Specific medication is usually not required. However, ongoing monitoring is still recommended.
A national study is currently underway to explore a non-invasive method of obtaining fetal DNA from maternal blood, which could significantly improve the ability to determine a baby’s genetic status and tailor maternal treatment accordingly. This research offers hope for more precise and personalized care in the future.
The increasing awareness of MODY-2, particularly its presentation during pregnancy, is leading to more accurate diagnoses and improved management for affected individuals and their families. Early identification and appropriate care are key to ensuring healthy outcomes for both mother and child.
If you are concerned about diabetes or gestational diabetes, please consult with your healthcare provider for personalized advice and evaluation.
